Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sphingosine kinase 1 promotes liver fibrosis by preventing miR‐19b‐3p‐mediated inhibition of CCR2
Tian Lan, Changzheng Li, Guizhi Yang, et al.
Hepatology (2018) Vol. 68, Iss. 3, pp. 1070-1086
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

M2b macrophage polarization and its roles in diseases
Lexun Wang, Sheng-xi Zhang, Huijuan Wu, et al.
Journal of Leukocyte Biology (2018) Vol. 106, Iss. 2, pp. 345-358
Open Access | Times Cited: 693
Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice
Xianjun Luo, Honggui Li, Linqiang Ma, et al.
Gastroenterology (2018) Vol. 155, Iss. 6, pp. 1971-1984.e4
Open Access | Times Cited: 311
Hepatic macrophages: Key players in the development and progression of liver fibrosis
Da Cheng, Jin Chai, Huiwen Wang, et al.
Liver International (2021) Vol. 41, Iss. 10, pp. 2279-2294
Open Access | Times Cited: 132
Functional roles of sphingolipids in immunity and their implication in disease
Mingyu Lee, Suh Yeon Lee, Yoe‐Sik Bae
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 6, pp. 1110-1130
Open Access | Times Cited: 70
Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis
Liang Shan, Fengling Wang, Dandan Zhai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114472-114472
Open Access | Times Cited: 48
Recent understanding of the mechanisms of the biological activities of hesperidin and hesperetin and their therapeutic effects on diseases
Zhongkai Ji, Wei Deng, Dong Chen, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26862-e26862
Open Access | Times Cited: 18
Sphingosine-1-Phosphate and Macrophage Biology—How the Sphinx Tames the Big Eater
Andreas Weigert, Catherine Olesch, Bernhard Brüne
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 102
The Roles and Mechanisms of lncRNAs in Liver Fibrosis
Zhi He, Deying Yang, Xiaolan Fan, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1482-1482
Open Access | Times Cited: 102
Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
Liteng Lin, Heng-Ye Gong, Rui Li, et al.
Advanced Science (2020) Vol. 7, Iss. 7
Open Access | Times Cited: 76
Epigenetic regulation in fibrosis progress
Taixiong Xue, Xingyu Qiu, Hongyao Liu, et al.
Pharmacological Research (2021) Vol. 173, pp. 105910-105910
Closed Access | Times Cited: 72
The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation
Wenjie Zhang, Guangyan Zhangyuan, Fei Wang, et al.
Immunity (2021) Vol. 54, Iss. 6, pp. 1168-1185.e8
Open Access | Times Cited: 64
Macrophage‐specific FGF12 promotes liver fibrosis progression in mice
Santie Li, Bin Zhou, Mei Xue, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 816-833
Closed Access | Times Cited: 43
Polydatin: A Critical Promising Natural Agent for Liver Protection via Antioxidative Stress
Dandan Tang, Qing Zhang, Huxinyue Duan, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 41
The role and therapeutic targeting of the CCL2/CCR2 signaling axis in inflammatory and fibrotic diseases
Shan Guo, Qi Zhang, Yingjie Guo, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis
Xin Chen, Hai-Di Li, Fang‐tian Bu, et al.
Theranostics (2020) Vol. 10, Iss. 11, pp. 4851-4870
Open Access | Times Cited: 69
Crosstalk network among multiple inflammatory mediators in liver fibrosis
Hanjing Zhangdi, Si-Biao Su, Fei Wang, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 33, pp. 4835-4849
Open Access | Times Cited: 59
Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β
Alexis Paulina Jiménez‐Uribe, Tania Gómez‐Sierra, Omar Emiliano Aparicio‐Trejo, et al.
Cellular Signalling (2021) Vol. 87, pp. 110123-110123
Closed Access | Times Cited: 49
Non-coding RNAs modulate function of extracellular matrix proteins
Nader Akbari Dilmaghani, Hamed Shoorei, Guive Sharifi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 136, pp. 111240-111240
Open Access | Times Cited: 46
Single-cell transcriptome analysis reveals liver injury induced by glyphosate in mice
Jiangpeng Wu, Xiuping Sun, Chun‐Yi Wu, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 20
Nanomedicine‐encouraged cellular autophagy promoters favor liver fibrosis progression reversal
Cheng Qian, Yan Zhang, Xiaoyang Chen, et al.
View (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 8
PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target
Shaoping She, Xiaoning Wu, Danfeng Zheng, et al.
Journal of Hepatology (2019) Vol. 72, Iss. 3, pp. 506-518
Open Access | Times Cited: 54
Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis
Xin Chen, Wanxia Li, Yu Chen, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 10
Open Access | Times Cited: 52
Toxicological Risk Assessments of Iron Oxide Nanocluster- and Gadolinium-Based T1MRI Contrast Agents in Renal Failure Rats
Qinjie Weng, Xi Hu, Jiahuan Zheng, et al.
ACS Nano (2019) Vol. 13, Iss. 6, pp. 6801-6812
Closed Access | Times Cited: 48
The protective effects of fibroblast growth factor 10 against hepatic ischemia-reperfusion injury in mice
Santie Li, Zhongxin Zhu, Mei Xue, et al.
Redox Biology (2021) Vol. 40, pp. 101859-101859
Open Access | Times Cited: 40
Isoliquiritigenin alleviates the development of alcoholic liver fibrosis by inhibiting ANXA2
Na Liu, Min Liu, Mengwei Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114173-114173
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top